SMTL ID : 3giz.1

Crystal structure of the Fab fragment of anti-CD20 antibody Ofatumumab

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.20 Å

Oligo State

hetero-1-1-mer

Ligands

3 x ZN: ZINC ION(Non-covalent)

ZN.1: 2 residues within 4Å: Chain A: E.79, E.81 3 PLIP interactions: 3 interactions with chain A Metal complexes: A:E.79, A:E.81, A:E.81 ZN.2: 4 residues within 4Å: Chain A: N.137, N.138, S.174 Chain B: H.173 1 PLIP interactions: 1 interactions with chain B Metal complexes: B:H.173 ZN.3: 1 residues within 4Å: Chain A: E.1 1 PLIP interactions: 1 interactions with chain A Metal complexes: A:E.1

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Du, J. et al., Structure of the Fab fragment of therapeutic antibody Ofatumumab provides insights into the recognition mechanism with CD20. Mol.Immunol. (2009)

Release Date

2009-05-26

Peptides

Fab fragment of anti-CD20 antibody Ofatumumab, light chain: A
Fab fragment of anti-CD20 antibody Ofatumumab, heavy chain: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
L

B
H

Fab fragment of anti-CD20 antibody Ofatumumab, light chain

Fab fragment of anti-CD20 antibody Ofatumumab, heavy chain

Related Entries With Identical Sequence